LYSTO:淋巴细胞评估黑客马拉松与基准数据集
LYSTO: The Lymphocyte Assessment Hackathon and Benchmark Dataset
AI总结:
本文介绍LYSTO淋巴细胞评估黑客马拉松,参赛者在极短时间内自动评估CD3/CD8染色病理图像中的T细胞数量,部分方法达到病理学家水平,赛后成为公开基准数据集与自动评估平台。
摘要:
我们介绍LYSTO,即淋巴细胞评估黑客马拉松,该活动与在中国深圳举行的MICCAI 2019会议同期举办。该竞赛要求参赛者自动评估经CD3和CD8免疫组织化学染色的结肠癌、乳腺癌和前列腺癌组织病理学图像中的淋巴细胞数量,特别是T细胞数量。与医学图像分析领域的其他挑战赛设置不同,LYSTO参赛者仅有几个小时来解决这一问题。在本文中,我们描述了该黑客马拉松的目标和多阶段组织方式;我们描述了所提出的方法和现场结果。此外,我们展示了赛后结果,其中我们展示了所提出的方法在一组独立的肺癌切片上的表现,该切片不属于初始竞赛的一部分,并对所提出的方法与病理学家小组在淋巴细胞评估方面进行了比较。我们表明,一些参赛者能够在淋巴细胞评估方面达到病理学家水平的表现。黑客马拉松结束后,LYSTO作为轻量级的即插即用基准数据集保留在grand-challenge网站上,并配备了一个自动评估平台。LYSTO已支持了肿瘤学中淋巴细胞评估方面的多项研究。LYSTO将成为一个面向深度学习和数字病理学的长期教育性挑战赛,可通过https://lysto.grand-challenge.org/访问。
英文摘要:
We introduce LYSTO, the Lymphocyte Assessment Hackathon, which was held in conjunction with the MICCAI 2019 Conference in Shenzen (China). The competition required participants to automatically assess the number of lymphocytes, in particular T-cells, in histopathological images of colon, breast, and prostate cancer stained with CD3 and CD8 immunohistochemistry. Differently from other challenges setup in medical image analysis, LYSTO participants were solely given a few hours to address this problem. In this paper, we describe the goal and the multi-phase organization of the hackathon; we describe the proposed methods and the on-site results. Additionally, we present post-competition results where we show how the presented methods perform on an independent set of lung cancer slides, which was not part of the initial competition, as well as a comparison on lymphocyte assessment between presented methods and a panel of pathologists. We show that some of the participants were capable to achieve pathologist-level performance at lymphocyte assessment. After the hackathon, LYSTO was left as a lightweight plug-and-play benchmark dataset on grand-challenge website, together with an automatic evaluation platform. LYSTO has supported a number of research in lymphocyte assessment in oncology. LYSTO will be a long-lasting educational challenge for deep learning and digital pathology, it is available at https://lysto.grand-challenge.org/.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。